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Summary 
Statl and Stat3 are latent transcriptional factors acti- 
vated initially through phosphorylation on single tyro- 
sine residues induced by cytokine and growth factor 
occupation of cell surface receptors. Here we show 
that phosphorylation on a single serine (residue 727) 
in each protein is also required for maximal transcrip- 
tional activity. Both cytokines and growth factors are 
capable of inducing the serine phosphorylation of 
Statl and Stat3. These experiments show that gene 
activation by Statl and Stat3, which obligatorily re- 
quire tyrosine phosphorylation to become active, also 
depends for maximal activation on one or more of the 
many serine kinases. 
Introduction 
The STAT proteins (signal transducers and activators of 
transcription) are latent transcription factors that become 
activated by phosphorylation on tyrosine in response to 
polypeptide-receptor interaction at the cell surface (Dar- 
nell et al., 1994). The activated STATs dimerize, translo- 
cate to the cell nucleus, and bind specific DNA elements. 
The STAT proteins were originally recognized in studies 
of interferon (z (IFN-(~) and IFN~ transcriptional ctivation: 
Statl and Stat2 are phosphorylated in response to IFN-(z 
(Schindler et al., 1992b), they heterodimerize (Schindler 
et al., 1992b; Qureshi et al., 1995), and together with a 
48 kDa protein that is not phosphorylated (Fu et al., 1990; 
Veals et al., 1992), they bind to the IFN-(x-specific DNA 
element, the IFN-stimulated response element (Levy et 
al., 1988). Statl, but not Stat2, is activated by IFN-7 (Shuai 
et al., 1992), homodimerizes (Shuai et al., 1994), translo- 
cates to the nucleus, and binds to a different DNA element, 
the iFN-3,-activated site (GAS) (Decker et al., 1991; Lew 
et al., 1991). Stat3 (Zhong et al., 1994a, 1994b), which 
proved identical to the acute phase response factor (Akira 
et al., 1994), was the first of a series of additional STAT 
family members to be described and is activated by ligands 
that bind to receptor-tyrosine kinases such as epidermal 
growth factor (EGF), platelet-derived growth factor (PDGF), 
and colony-stimulating factor 1, as well as cytokine recep- 
tors such as interleukin-6 (IL-6), which lack intrinsic tyro- 
sine kinases but have janus kinases associated with their 
internal domains (Akira et al., 1994; Schindler and Darnell, 
1995). Stat3 is also activated by IFN-~ (Beadling et ai., 
1993; Boulton et al., 1995), but not by IFN-7 (Beadling et 
al., 1993; Akira et al., 1994; Zhong et al., 1994b). Statl can 
be activated also by EGF and PDGF, but is not activated as 
strongly as Stat3 by cytokines such as IL-6. 
Cell lines (U3A cells) that completely lack Statl(~ and 
Statll~, which is missing the COOH-terminal 38 amino 
acids of Statl~, are defective in response to either IFN-~ 
or IFN-7 (Muller et al., 1993). Cells that lack Stat2 are 
deficient for the IFN-a response, but still respond to IFN-7 
(Leung et al., 1995). in U3A cells, Statl a or Stat113 suffices 
to restore the IFN-(~ pathway for most genes (Muller et al., 
1993). However, Statla can restore the IFN-~, pathway, 
but Statll~ cannot (Muller et al., 1993), despite the fact 
that Stat113 is phosphorylated on tyrosine, dimerizes, en- 
ters the nucleus, and can bind DNA (Muller et al., 1993; 
Shuai et al., 1993a). Since the only difference between 
Statl(~ and Statll3 is the lack of the COOH-terminal 38 
amino acids in Stat113, this focused our attention on these 
residues in IFN~-dependent ranscriptional activation. 
Furthermore, we had earlier encountered some paral- 
lels and some differences in drug sensitivity in the IFN-~ 
and IFN-7 transcriptional pathways (Lew et al., 1989), 
whi(~h remained unexplained. Both pathways are inhibited 
by genistein or staurosporine, which are primarily inhibi- 
tors of tyrosine phosphorylation, in line with the obligatory 
requirement for tyrosine phosphorylation for STAT dimer 
formation and DNA binding (Schindler et al., 1992b; Shuai 
et al., 1993a). However, H7, which is also a serine/threo- 
nine kinase inhibitor, blocked IFN-7-induced transcription, 
but had very much less effect on IFN-a-induced transcrip- 
tion (Lew et al., 1989). In addition, s2p is incorporated into 
phosphoserine in Statl(~ to a much greater extent than in 
Stat113 in response to IFN-~, (Shuai et al., 1992, 1993a). 
All of these results suggested that perhaps Statl(~ con- 
tained a critical serine in the 38 terminal amino acids that 
served in gene activation. The present experiments dem- 
onstrate that Ser-727, which is lacking in Stat113, is in fact 
phosphorylated, possibly through the mitogen-activated 
protein (MAP) kinase pathway. Furthermore, the phos- 
phorylation of Ser-727 is induced by IFN-.y and PDGF treat- 
ments. Finally, Statl protein that is mutant in Ser-727 (Ser- 
727~Ala-727) is phosphorylated normally on tyrosine, 
dimerizes, and binds DNA, but in cells bearing the mutant 
protein, only about 20% as much IFN-'y-dependent tran- 
scription occurs. Evidence is also given that Stat3 is phos- 
phorylated on an analogous serine residue and that full 
transcriptional activation by Stat3 also requires serine 
phosphorylation. 
Results 
Sequence Alignment of STATs Reveals 
Conserved PMSP Box 
Amino acid sequence comparison of the known STATs 
shows conserved regions scattered throughout nearly the 
entire length of the proteins (Fu et al., 1992; Schindler et 
al., 1992a; Akira et al., 1994; Hou et al., 1994; Wakao et 
al., 1994; Yamamoto et al., 1994; Zhong et al., 1994a, 
1994b). However, the COOH-terminal region of the STATs 
(from residue -710 to the end) is quite diverse (Figure 1), 
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Figure 1. Alignment of Amino Acid Sequences at COOH-Terminal of 
STAT Proteins 
Statll3 lacks the COOH-termina138 amino acids of Statl ~, and within 
this region the amino acid sequence PMSP (boxed) is highly conserved 
in Statl~, Stat3, Stat4, and Stat5. Amino acids residues are shown 
with standard single-letter abbreviations. 
Stat3, Stat4, and Stat5 (PLSP). This conserved sequence 
is missing from the Stat113 spliced variant encoded by the 
Statl gene (Schindler et al., 1992a; Yan et al., 1995) and 
is also missing in Stat2 (Fu et al., 1992) and Stat6 (Hou 
et al., 1994), both of which are about 100 amino acids 
longer than Statl, Stat3, Stat4, and Stat5. The PMSP se- 
quence is similar to the MAP kinase recognition consensus 
sites (Clark-Lewis et al., 1991 ; Gonzalez et al., 1991). We 
had earlier observed in mapping the 32P-labeled tyrosine 
phosphopeptides induced by IFN-a in Statl and Stat2 that 
Stat2 contained very little if any labeled phosphoserine, 
and as mentioned above Statla did contain phosphoser- 
ine that was lacking in Statll3 after IFN-y treatment. 
Ser-727 of Statla Is the Major Serine Kinase 
Target In Vivo 
Therefore, we first determined directly whether the Ser- 
727 residue of Statl could be phosphorylated in vivo. U3A 
cells (Muller et al., 1993) that lack Statl protein were per- 
manently transfected with expression vectors for wild-type 
Statl~ or mutant Statlas (Ser-727-*Ala-727). Individual 
clones of cells expressing Statla or Statl as to compara- 
ble levels were used in comparisons in the remainder of 
this work. Cells expressing either wild-type Statl~ or 
Statlas were exposed to [32P]orthophosphate for 2.5 hr 
and treated with IFN-y for 20 min. (As a control, the wild- 
type cells were also labeled without IFN-y treatment.) Pro- 
tein extracts were prepared from both nucleus and cyto- 
plasm, exposed to anti-StatiC, an antiserum against the 
COOH-terminus of Statl, and the 91 kDa 32P-labeled band 
was selected after SDS-polyacrylamide gel electrophore- 
sis (SDS-PAGE) (Figure 2A). The labeled Statl samples 
were digested with trypsin, applied to thin-layer cellulose 
plates, and separated by a two-dimensional analysis (Fig- 
ure 2B; Walaas and Nairn, 1989). Autoradiographs of the 
separated samples revealed an IFN-y-induced phospho- 
peptide (labeled 1 in Figure 2Bb) that migrated similarly to 
the earlier described phosphotyrosine-containing peptide, 
GIYTEK (Shuai et al., 1992, 1993a). This phosphopeptide 
was not present in the sample from cells expressing wild- 
type protein that were not treated with IFN~ (Figures 2Ba 
and 2Bd). A second prominently labeled peptide (labeled 
2 in Figure 2B; actually a double spot in some samples, 
possibly owing to either incomplete trypsin digestion or 
perhaps oxidation of the methionine residue in the peptide) 
contained phosphoserine (Figures 2Ba, 2Bb, 2Bd, and 
2Be; Figures 2C and 2D). This phosphoserine-containing 
peptide was present in either nuclear or cytoplasmic sam- 
ples of IFN-.r-treated or untreated U3A-derived cells con- 
taining the wild-type protein, but was absent from cells 
containing the mutant protein Statlas (Figures 2Bc and 
2Bf). Thus, a single serine to alanine mutation at residue 
727 apparently removed from Statl the major target site 
for serine phosphorylation. Note that in these samples of 
U3A-derived cells (Figure 2) the serine phosphorylation 
occurred whether or not the cells were treated with IFN~. 
There was somewhat more phosphoserine than phospho- 
tyrosine, suggesting that more Statl~ molecules were 
phosphorylated on serine than on tyrosine, since there is 
apparently a single residue of each amino acid phosphory- 
lated, at least in these Statlg-complemented U3A cells. 
The site of in vivo serine phosphorylation was confirmed 
as residue 727 by synthesizing a 29 residue long peptide 
matching the human Statl~ sequence from residue 712 
to 740 (Figure 2D). This peptide was treated with purified 
Xenopus MAP kinase in the presence of ['y-32P]ATP. The 
resulting labeled peptide was subjected to two-dimen- 
sional separation and eluted from the thin-layer chroma- 
tography (TLC) plate. The purified 32P-labeled peptide was 
then digested with trypsin, and the synthetic and authentic 
[~2P]phosphoserine-labeled tryptic peptides were com- 
pared by two-dimensional analysis (Figure 2D). The two 
labeled peptides migrated very similarly (each sample was 
analyzed in a different chromatography tank, leading to 
the slight differences in migration) and when mixed yielded 
a single serine-containing spot (Figure 2Dc), the conven- 
tional method of demonstrating phosphopeptide identity 
(Walaas and Nairn, 1989). The experiment also estab- 
lished that the Statl peptide was a substrate for the MAP 
kinase, which was suspected to be possible because the 
sequence of the potential phosphorylation site, PMSP, 
matched the known MAP kinase recognition site (Clark- 
Lewis et al., 1991; Gonzalez et al., 1991). This, of course, 
does not prove the nature of the responsible kinase inside 
cells. 
Induction of Serine Phosphorylation 
We sought to determine a possible inductive signal for the 
serine phosphorylation, first by depriving Statler-comple- 
mented U3A cells of serum and testing whether without 
IFN-y treatment such cells lacked Statl~ Ser-727 phos- 
phorylation. Figure 3 shows that serum starvation (for 14 
hr) did not block the labeling of the serine-containing phos- 
phopeptide, which was labeled about half as well as in 
cells treated with IFN-7 (compare Figures 3Ba and 3Bb). 
We then became aware that HT1080 cells, the parental 
cell line of U3A cells, have a well-documented, mutant 
constitutively activated N-ras allele that might cause Ser- 
727 to be permanently phosphorylated (Hall et al., 1983; 
Brown et al., 1984). 
We therefore shifted to NIH 3T3 cells, diploid mouse 
fibroblasts with normal Ras protein(s). These cells were 
deprived of serum for 14 hr, and samples were then la- 
STAT Activation Requ|res Phosphoserine 
243 





c N C N C N 
( 
1 2 3 4 5 6 
IFN-y 
Figure 2. Phosphopeptide Mapping of Trypsin Digests of ~P-Labeled 
Statl Proteins and Identification of the Phosphoserine Residue in 
Statl 
(A) Immunoprecipitation of 32P-labeled Statl of untreated (lanes 1-2) 
or IFN-',f-treated (lanes 3-6) cytoplasmic extracts (lanes 1, 3, and 5) 
or nuclear extracts (lanes 2, 4, and 6) of U3A Statl~ (lanes 1-4) or 
U3A Statl~s (lanes 5 and 6) cells. 
(B) Tryptic phosphopeptide map of 32P-labeled Statl of untreated (a 
and d) or IFN-y-treated (b, c, e, and f) cytoplasmic extracts (a, b, and 
c) or nuclear extracts (d, e, and f) of U3A Statl~ (a, b, d, and e) or 
U3A Statles (c and f). 
(C) Phosphoamino acid analysis of the spot 2 phosphopeptide from 
(13) purified from TLC plates (left) compared with the migration of pTyr, 
pThr, and pSer (right). 
(D) Identification of the phosphoserine residue 727 in Stat16. Authentic 
~P-labeled tryptic phosphopeptides (a) from Statl~ were compared 
with in vitro labeled synthetic phosphopeptide (b); synthetic peptide, 
VHPSRLQTTDNLLPMSPEEFDEVSRIVGS (Bio-Sythesis, Incorpo- 
rated), was ~P labeled by MAP kinase in vitro, digested with trypsin, 
and analyzed by two-dimensional peptide mapping either alone (b) or 
mixed with the synthetic peptide (c). 
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beled with [32P]O4 for 2.5 hr and treated for 20 min with 
IFN-'y or PDGF or left untreated. A clear induction by IFN-y 
was seen in both phosphopeptide 1, the tyrosine-contain- 
ing peptide, and in phosphopeptide 2, the Ser-727-con- 
taining peptide. After treatment with PDGF, a similar 
smaller degree of induction in tyrosine phosphorylation 
and a robust induction of serine phosphorylation were also 
observed (Figures 3Bd and 3Be). Two additional phospho- 
peptides that gave weaker signals were detected in the 
phosphoproteins precipitated by anti-Statl~ from the 
PDGF-induced cells. Since PDGF also activates Stat3 in 
these cells and Statl-Stat3 heterodimers form (Zhong et 
al., 1994b), these two phosphopeptides could be due to 
phosphorylation of Stat3 or other coprecipitating phos- 
phorylated proteins. 
Tyrosine Phosphorylation and DNA Binding 
of Statlas 
We next tested the functional importance of phosphoryla- 
tion of Statl on Ser-727 using the mutant construct in 
which alanine was substituted for serine at residue 727. 
We first examined the phosphorylation of tyrosine and the 
ability of the Statlas mutant to bind DNA compared with 
that of wild-type protein. Cells expressing either wild-type 
Statla or Statlas protein were treated with IFN-y for 20 
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Figure 3. Inducible and Constitutive Phos- 
phorylation of Ser-727 in Statla in Two Cell 
Lines 
(A) Immunoprecipitation of 32P-labeled Statle 
of untreated (lanes 1 and 3) or IFN-y-treated 
(lanes 2 and 5) and PDGF-treated (lane 4) se- 
rum-starved U3A cells bearing Statle (lanes 1 
and 2) or NIH 3T3 cells (lanes 3, 4, and 5). 
(B) Tryptic phosphopeptide map of Statle in 
serum-starved U3A Statla cells (a and b) and 
• NIH 3T3 cells (c, d, and e) treated with IFN-,y 
(b and e) or PDGF (d) for 20 rain or left untreated 
(a and c). 
mobility shift assays (EMSAs) (Fried and Crothers, 1981) 
with nuclear extracts of cells treated for 20 min with IFN-7 
showed equal induction of DNA-binding activity using the 
32P-labeled interferon-regulatory factor 1 (IRF-1) GAS oli- 
gonucleotide (Sims et al., 1993) as a probe (Figure 4A). 
In fact, both wild-type and mutant proteins bound equally, 
but to varying extents (data not shown) using three differ- 
ent labeled DNA probes: binding with M67 SIE was greater 
than with IRF-1 GAS, which was greater than with Ly6E 
GAS (Wagner et al., 1990; Khan et al., 1993; Sims et al., 
1993). The gel shift bands were  specif ic  because the 
Stat lC  antiserum produced a supershift, while the preim- 
mune serum had no effect (Figure 4A, lanes 3, 4, 7, and 
8). In addition, both wild-type and mutant proteins were 
equally phosphorylated on tyrosine, as tested by anti- 
phosphotyrosine antibody reaction with Stat l  immunopre- 
cipitates separated on polyacrylamide gels (Figures 4B 
and 4C). 
Requirement for Ser-727 in Stat le  
Transcriptional Induction 
Having demonstrated that serine phosphorylation of resi- 
due 727 in Stat l  occurs in vivo and that mutant protein 
lacking this residue could be phosphorytated on tyrosine 
and bind DNA, we tested for the effect on IFN-y-induced 
transcription. Two different experiments indicated that the 
Ser-727 was required for maximal IFN-y-induced tran- 
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Figure 4. DNA Binding and Tyrosine Phos- 
phorylation of Ser-727~Aia-727 Mutant of 
Statla in U3A-Complemented Cells 
(A) Gel mobility shift analysis was performed 
with ~P-labeled IRF-1 GAS probe. Nuclear ex- 
tracts were prepared from U3A Statl(z cells 
(lanes 1-4) and U3A Statl~s (the Ser- 
727~Ala-727 mutant, lanes 5-8) cells un- 
treated (lanes 1 and 5) or treated with IFN-y 
(lanes 2-4 and 6-8). Preimmune serum (pi, 
lanes 3 and 7) or anti-StatiC serum (1C, lanes 
4 and 8) was added in the reaction. 
(B) Western blot analysis. Whole-cell lysate 
from U3A cells (lane 1), U3A cells comple- 
mented with wild-type Statl a (lane 2), and U3A 
cells complemented with mutant Statl (zs (lane 
3) was subjected to SDS-PAGE and blotted 
with anti-Statl COOH-terminal serum (anti- 
StatlC). 
(C) Protein immunoblot of anti-StatiC precipi- 
tates with anti-phosphotyrosine antibody. 
Whole-cell lysate from U3A Statl a cells (lanes 
1 and 2) or U3A Statl=zs cells (lanes 3 and 4) 
either treated with IFN-y (lanes 2 and 4) or un- 
treated (lanes 1 and 3) were precipitated with 
anti-StatiC serum and probed with anti- 
phosphotyrosine antibody (top). The blot was 
then stripped and reprobed with anti-Statl mid- 
dle serum (anti-Statlm, bottom). 
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type Statla or the mutant Statlas plus a reporter gene 
(luciferase) construct with three GAS sites from the pro- 
moter of the IFN-7-inducible Ly6E gene (Khan et al., 1993; 
Shuai et al., 1993a). After 16 hr of transfection, the cells 
were either treated with IFN-~, or left untreated, and ex- 
tracts were assayed for luciferase activity 6 hr later. As a 
control, a transfection of Statl~ was also carried out. 
Statl I~ lacks the terminal 38 amino acids of Statl a, includ- 
ing the Ser-727 residue, and is known not o drive IFN-~,- 
induced transcription (Muller et al., 1993; Shuai et al., 
1993a). Stat113, however, is phosphorylated on tyrosine, 
dimerizes, enters the cell nucleus in vivo, and can bind 
DNA in in vitro tests (Shuai et al., 1993a). The wild-type 
Statla produced a 25- to 30-fold higher luciferase signal 
after IFN-~ induction, whereas transfection of the StatlJ~ 
gave almost no increased signal from the reporter con- 
struct. Statlas gave about a 4- to 5-fold increase, consis- 
tent with the conclusion that a large fraction but not all of 
the IFN-'~ transcriptional response r quired not only the 
phosphotyrosine (Shuai et al., 1993a), but phosphoserine 
on residue 727 (Figure 5A). 
A second experiment tested the response of an endoge- 
nous gene that is transcriptionally induced by IFN-'y treat- 
ment. Permanently tranfected U3A-derived cell lines con- 
taining wild-type Statla or mutant Statlas were treated 
with IFN-7 for 3 hr, and poly(A) ÷ RNA was extracted and 
subjected to Northern blot analysis for mRNA from the 
IRF-1 gene (Maruyama et al., 1989), a gene that is tran- 
scriptionally induced by IFN-~' (Pine et al., 1990; Pine et 
al., 1994). There was about a 12-fold increase in IRF-1 
mRNA in cells containing wild-type Statla, whereas cells 
with Statlas were induced about 3-fold (Figures 5B and 
5C), consistent with the transfectional analysis in Figure 5A. 
Stat3 Also Requires Serine Phosphorylat ion 
for Maximal Transcriptional Activation 
Stat3 is highly similar to Statl in amino acid sequence 
and is activated by an array of ligands, some of which also 
activate Statl and some of which do not or do so weakly. 
We wished to test whether Stat3 would also require serine 
phosphorylation to activate transcription. Although Stat3 
is 770 amino acids long, 20 amino acids longer than 
Statla, the PMSP box is conserved in Stat3 in an analo- 
gous position in the COOH-terminus of the protein (see 
Figure 1). Furthermore, we knew from the experiments of 
Boulton et al. (1995) and the recent report of Zhang et al. 
(1995) that a ligand- and time-dependent retardation of 
Star3 in SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) had been observed after treatment with cells by 
several ligands. Moreover, in these experiments the serine 
kinase inhibitor H7 blocked the change to slower mobility, 
which indicated that the mobility shift might be due to ser- 
ine phosphorylation, since both the slow and fast forms 
were tyrosine phosphorylated. We therefore mutated 
Stat3 at Ser-727 and introduced it into COS (monkey) cells, 
which have a low amount of endogenous Stat3. We had 
earlier shown using these cells that the overexpressed 
Stat3 in COS cells can be activated by EGF (Zhong et 
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Figure 5. Transcriptional Activation Analysis of Statl•s 
(A) Luciferase assay. Transfection into U3A cells of a reporter gene 
(luciferase) plus either Statla, Statlas, or StatlJ3 expression con- 
structs for 16 hr was followed by a 6 hr IFN-7 treatment; extracts were 
prepared, and luciferase assays were carried out. Luciferase light units 
are plotted on the Y axis (open bars, untreated cells; closed bars, 
IFN~-treated cells). 
(B) Stimulation of IRF-1 mRNA accumulation by IFN-y in U3A Statla 
and U3A Statlas cells. Northern blot analysis of IRF-1 transcript. 
Poly(A) + RNA were collected from U3A Statla cells (lanes 1 and 2) 
or U3A Statlas cells (lanes 3 and 4) untreated (lanes 1 and 3) or 
treated with IFN-~, for 3 hr (lanes 2 and 4). The blot was probed with 
IRF-1 or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA. 
(C) Quantitation of IRF-1 transcripts in(B) by Phosphorlmager normal- 
ized to GAPDH. Open bars, untreated samples; closed bars, IFN-y- 
treated samples (7ng/rnl for 3 hr). 
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cells, the precipitates were subjected to electrophoresis, 
and Stat3 was detected by anti-tyrosine antibody; it was 
clear with wild-type protein that two tyrosine-phosphory- 
lated forms (the higher form, Stat3-H and the lower form, 
Stat3-L) were seen (Figure 6A, lane 1), indicating possible 
serine phosphorylation of the slower moving band. In the 
wild-type protein, the great majority was in the slow moving 
band. However, the mutation of Stat3, Ser-727~Ala-727, 
completely blocked the formation of the slower migrating 
band (Figure 6A, lane 2). The tyrosine phosphorylation of 
the mutant protein was equal to that of the wild-type pro- 
tein, and the ability to bind DNA after EGF induction was 
also unchanged by the Ser-727 mutation, as tested by 
EMSA using 32P-labeled M67 SIE (Wagner et al., 1990) 
(Figure 6). The binding of both wild type and mutant were 
identical using two other labeled probes, IRF-1 GAS (Sims 
et al., 1993) or Ly6E GAS (Khan et al., 1993; data not 
shown). These latter results on DNA binding are in accord 
with the experiments of Boulton et al. (1995), which 
showed Stat3 DNA binding to be equal in H7-treated and 
untreated cells. However, Zhang et al. (1995) report that 
Stat3 in a B-cell line activated by IL-6 binding was at least 
partially sensitive to H7 inhibition. We do not know the 
basis for this difference at present. 
We next tested the transcriptional inductive capability 
of the wild-type Stat3 compared with the Ser~Aia-727 mu- 
tant in an acute tranfection experiment. We have recently 
shown that U3A cells have a low endogenous Stat3 activa- 
tion by IFN-~, but a robust induction of newly introduced 
Stat3 (Horvath et al., 1995), and we therefore used that 
system in this test. The wild-type protein induced about 
20-fold a luciferase target gene driven by Stat3-binding 
sites, whereas the Stat3 mutant Ser~Ala-727 protein only 
induced the reporter gene about 8-fold. (Two additional 
experiments gave very similar results.) Thus, a phospho- 
serine at 727 in Stat3, like the phosphoserine at residue 
727 of Statl~, is required for maximal transcriptional cti- 
vation. 
Discussion 
In this report we note that a number of the STAT proteins 
contain a highly conserved potential serine kinase site in 
the COOH-terminal residues (Figure 1). In both Statl and 
Stat3, evidence for in vivo phosphorylation of this serine is 
provided, and itwas demonstrated that this phosphoserine 
was required for maximal transcriptional ctivation. In the 
case of serine phosphorylation of Statl of residue 727, 
we found in serum-starved NIH 3T3 cells that both PDGF 
and IFN-7, the most potent inducer of tyrosine phosphory- 
lation of Statl, also induced Statl serine phosphorylation. 
PDFG is known to activate MAP kinase (Hunter et al., 
1985), and it has also been claimed that IFN-y may be 
capable of activating the MAP kinase pathway in mono- 
cytes (Lui et al., 1994). In addition, we found that in U3A 
cells, which descend from a cell line (HT1080) with a domi- 
nantly activated N-ras allele (Hall et al., 1983; Brown et 
al., 1984), the Statle is constitutively phosphorylated on 
Ser-727 even after deprivation of serum, in such cells, 
IFN-y yielded only about a 2-fold increase in serine phos- 
phorylation (Figures 3Ba and 3Bb). Furthermore, EGF, 
IL-6, leukemia inhibitory factor, and ciliary neurotrophic 
factor induced the apparent serine phosphorylation of 
Stat3 (detected by Boulton et al. [1995]), as in lane 1 of 
Figure 6A, as a slower migrating band in wild-type Stat3. 
These ligands are also known to activate MAP kinase (Ahn 
and Krebs, 1990; Ahn et al., 1990; Boulton et al., 1994). 
Finally, the phosphorylation of Ser-727 was carried out in 
vitro by purified activated MAP kinase. Thus, it seems 
possible that MAP kinase may be capable of catalyzing 
phosphorylation ofthe STAT proteins, although we cannot 
be certain at present which serine kinase(s) might be ac- 
tive in this reaction. 
We note that not all STAT-activated transcriptional cti- 
vation apparently requires the phosphorylation ofSer-727. 
The IFN-~ activation of transcription that occurs through 
the assembly of the multiprotein complex interferon-stim- 
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Figure 6. DNA Binding, Tyrosine Phosphory- 
lation, and Transcription Activity of Stat3 Mu- 
tant Ser-727~Ala-727 
(A) Tyrosine phosphorylation f the wild-type 
(wt) and Ser-727-*Ala-727 mutant (m) of Stat3. 
Cell lysates from EGF-treated COS cells that 
were transfected either with wild-type (lane 1) 
or Ser-727-*Ala-727 mutant (lane 2) were pre- 
cipitated with anti-Stat3 COOH-terminal serum 
and probed with anti-phosphotyrosine anti- 
body (PY2O). 
(B) Gel mobility shift assay was performed with 
~2P-labeled M67 SIE probe. Nuclear extracts 
were prepared from EGF-treated COS cells 
that were transfected with either wild-type 
Stat3 (wt, lanes 1,3, and 4) or Ser-727~Ala- 
727 mutant (m, lanes 2, 5, and 6) of Stat3. Pre- 
immune serum (pi, lanes 3 and 5) or anti-Stat3 
COOH-terminal serum (3c, lanes 4 and 6) was 
included in the reaction. 
(C) Transcriptional ctivation analysis. U3A 
cells transfected with a 4x IRF-1 GAS-luciferase (4x IRF-1 GAS-LUC; Sims et al., [1993]) reporter plasmid together with either wild-type (wt) or 
Ser-727~Ala-727 mutant (m) of Stat3 expression constructs were treated with IFN-~ for 6 hr; cell extracts prepared and luciferase assays carried 
out. Luciferase light units were plotted on the Y axis (open bars, untreated; closed bars, IFN-a-treated). 
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ulated gene factor 3 (ISGF-3) on the IFN-~ response ele- 
ment can utilize Statll3 as well as Statla (Muller et al., 
1993); Statl B lacks the terminal 38 amino acids, including 
Ser-727, that are found in Statlcz. In addition, Stat2, which 
lacks the PMSP box (Figure 1), does not contain phospho- 
serine (Improta et al., 1994) (at least in U3A and 2fTGH 
cells) and appears to be the activating protein in the IFN-~- 
induced ISGF-3 complex; COOH-terminal truncation of 
Stat2, including loss of several acidic amino acids, elimi- 
nates IFN-~-induced transcription (S. A. Qureshi and 
J. E. D., unpublished data). 
Serine phosphorylation has been reported to increase 
transcriptional ctivation by a number of different proteins 
(Hunter and Karin, 1992). For example, the cAMP re- 
sponse element-binding (CREB) proteins are phosphory- 
lated on serine after induced increases in cAMP (Hoeffler 
et al., 1988; Gonzalez and Montminy, 1989; Sassone- 
Corsi, 1994). The catalytic subunit of protein kinase A is 
thought to be the responsible enzyme (Hoeffler et al., 
1988) for phosphorylating CR EB. The ternary complex fac- 
tor and the serum response factor that bind the c-fos pro- 
moter are phosphorylated on serine in response to poly- 
peptides owing to activated serine kinases, probably 
involving the p42/p44 MAP kinases (Treisman, 1994) or 
the pp90 rsk kinase (Rivera et al., 1993), respectively. Also, 
AP-1 is serine phosphorylated after phorbol ester treat- 
ment of cells (Karin and Smeal, 1992), possibly owing to 
a newly described kinase, Jnk (Hibi et al., 1993), which 
is related to the MAP kinases. In all these cases, the serine 
phosphorylation increases the effectiveness of the tran- 
scription factors already resident in the nucleus (Figure 7). 
A possible mechanism by which serine phosphorylation 
generally increases transcription has recently been de- 
scribed. Avery large (265 kDa) protein, CREB-binding pro- 
tein (Chrivia et al., 1993), which may act as a coactivator, 
binds to phosphorylated CREB or AP-1 protein much bet- 
ter than it does to unphosphorylated proteins (Arias et al., 
1994; Kwok et al., 1994). Thus, there may be a general 
requirement for many resident nuclear transcription fac- 
tors to be phosphorylated on serine to be maximally active 
in the assembly of active transcription complexes. 
We would draw a distinction (Figure 7) between tran- 
scriptional activation through serine phosphorylation of 
resident nuclear factors and those factors, like the STATs, 
that are only transiently activated and present briefly in 
the nucleus in response to polypeptide ligand activation 
(Shuai et al., 1992; Zhong et al., 1994b). Increased serine 
kinase activity triggered through Ras-MAP kinase activa- 
tion, cAMP elevation, protein kinase C activation, or activa- 
tion of serine kinase pathways from the cytokine receptors 
themselves might result in affecting any serine phos- 
phate-sensitive transcriptional factor resident in the nu- 
cleus at the time of a wave of serine kinase activity and 
might affect ongoing transcription by changing the rate. 
However, specific induction of genes from a transcriptional 
ground state near zero might not be accomplished alone 
by serine phosphorylation, but might require specific re- 
ceptor-kinase activation of proteins such as the STATs, 
which are first phosphorylated in the cytoplasm before 
dimerization and nuclear translocation. As we show, of 
RTKs Ion 
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Figure 7. STAT-Directed Transcription: Necessity of Tyrosine Phos- 
phorylation and Link to Serine Kinases 
A schematic diagram of transcriptional activation by induced transcrip- 
tion factors contrasting those factors that are constitutively in the nu- 
cleus and are activated by serine phosphorylation with factors like 
the STATs, which require cytoplasmic activation as well as serine 
phosphorylation. 
course, further increase (or probably decrease, in some 
cases) in transcriptional activity could await serine phos- 
phorylation of the STAT. The possibility of obligatory par- 
ticipation of a protein that does not depend primarily on 
a serine phosphorylation preserves the specificity inherent 
in the protein-protein interaction of the ligand-receptor 
complex, and some such mechanism would seem to be 
required if different polypeptide ligands do indeed trigger 
different patterns of gene activity from previously quies- 
cent genes. 
Experimental Procedures 
Cell Culture and Antibodies 
U3A cells, NIH 3T3, and COS cells were grown in DMEM supple- 
mented with 10% calf serum (Hyclone Laboratories Incorporated). For 
serum starvation experiments, cells were deprived of serum (0%) for 
14 hr. Stable cell lines were selected with G418 (300 pg/ml; GIBCO 
BRL) in DMEM supplemented with 10% calf serum. Individual c ones 
were then selected and expanded in the presence of G418 (100 p,g/ 
ml). Anti-StatiC and Stat3C sera were raised in rabbit as previously 
described (Schindler et al., 1992a, 1992b; Zhong et al., 1994a, 1994b). 
Anti-phosphotyrosine antibody PY20 was purchased from Transduc- 
tion Laboratories. IFN-7 (7 nglml; a gift from Amgen) and PDGF (100 
ng/ml; obtained from the National Institutes of Health) treatments of 
cells were for 20 rain. 
Plasmid Constructions 
The STAT mammalian expression plasmids were made by inserting 
the coding region into the Notl and ApaLI (Statl ~, Statl~s, wild-type, 
and Ser-727~Ala-727 mutant of Stat3) or Notl (Statll3) sites of the 
expression vector RC/CMV (Invitrogen). The 3 x Ly6E GAS-LUC and 
4x IRF-1 GAS-LUC were made by subcloning three copies of Ly6E 
GAS (Khan et al., 1993) or four copies of IRF-1 GAS (Sims et al., 1993) 
oligonucleotides, respectively, into the BamHI site of TK-LUC (Shuai 
et al., 1993a, 1993b). pCMV~,, a ~-galactosidase expression plasmid, 
was purchased from Invitrogen. Oligonucleotide-directed mutagene- 
sis was performed according to a protocol described in Ausubel et al. 
(1994). 
Phosphopeptide Mapping and Phosphoamino 
Acids Analyses 
Cells were starved for 2 hr in phosphate-free DMEM (GIBCO, BRL) 
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with or without 10% calf serum dialyzed against a HEPES buffer (1.8 
mM CaCI2, 5 mM KCI, 0.8 mM MgSO4, 110 mM NaCI, 44 mM NaHCO3, 
and 25 mM HEPES [pH 7.3]). The labeling was carried out with 0.5 
mCi/ml of [32P]orthophosphate (DuPont) for 2.5 hr in medium otherwise 
lacking phosphate. Cell lysates were prepared and precleared with 
preimmune serum and protein A-agarose (Oncogene Science). The 
Statl(x proteins were immunoprecipitated with anti-StatiC serum, sub- 
jected to 7.5% SDS-PAGE and autoradiography. The 32P-labeled 
Statle proteins were recovered after SDS-PAGE, digested with tryp- 
sin (100 ng/rnl; Worthington Biochemical Corporation) in 50 mM 
NH4HCO3. Phosphopeptides were separated by electrophoresis at pH 
3.5, followed by chromatography on thin-layer cellulose plates (Kodak) 
and visualized by autoradiography (Walaas and Nairn, 1989). Individ- 
ual phosphopeptides were eluted from TLC plates with pyridine and 
hydrolyzed in 6 M HCI at 110°C for 90 rnin. Phosphoarnino acids were 
determined by electrophoresis at pH 1.9 and then at pH 3.5 on the 
TLC plate (Walaas and Nairn, 1989). 
In Vitro Phosphorylation Assay 
Synthetic peptide (5 ~g) was phosphorylated by 5 ~1 of purified Xeno- 
pus MAP kinase (a gift from Dr. J. Mailer, University of Colorado School 
of Medicine) in 27 mM Mg acetate, 20 mM HEPES (pH 7.4), 0.1 mM 
ATP, and 10 pCi of [7-32P]ATP (DuPont) at 30°C for 20 rain and sepa- 
rated by the two-dimensional technique on a thin-layer cellulose plate. 
The 32P-labeled peptide was then eluted from the TLC plate and sub- 
jected to phosphopeptide mapping analysis. 
Cell Extracts and Immunoblot 
Cells were lysed in hypotonic buffer (20 mM HEPES [pH 7.9], 10 rnM 
KCI, 0.1 mM Na~VO4, 1 mM EDTA, 10% glycerol, 1 mM PMSF, 3 mg/ 
ml aprotinin, 1 mg/ml Pepstain, 20 mM NaF, and 1 mM DTT) with 
0.2% NP-40 on ice for 10 min. After centrifugation at 4°C (13,000 rpm 
in microfuge) for 1 min, supernatants were collected as cytoplasmic 
extracts. Nuclear extracts were prepared by resuspension of the crude 
nuclei in high salt buffer (hypotonic buffer with 20O/o glycerol and 420 
mM NaCI) at 4°C with rocking for 30 rain, and the supernatants were 
collected after centrifugation at 4°C (13,000 rpm) for 10 rain. Whole-cell 
lysates were prepared as described previously (Shuai et al., 1992). 
Immunopreeipitation and Western blots were carried out by standard 
methods (Ausubel et al., 1994). Anti-StatiC and anti-Stat3C sera were 
diluted 1:1000 for Western blots. For anti-phosphotyrosine blots, the 
precipitates were resolved on 7.50/0 SDS-polyacrylamide gel and 
transferred to nitrocellulose membranes (Schleicher & Schuell). The 
membranes were then probed with anti-phosphotyrosine antibody 
PY20 (1:1000). 
EMSA 
Nuclear extracts were used for EMSA, which was carried out on 4% 
29:1 polyacrylarnide:bisacrylamide gels as described previously (Fried 
and Crothers, 1981) with 32P-labeled IRF-1 GAS (Sims et al., 1993) or 
M67 SIE (Wagner et al., 1990) oligonucleotides as probes. 
Luciferass Assay 
Transfection was done by calcium-phosphate method (Ausubel et al., 
1994) with individual RC/CMV-Statl or RC/CMV-Stat3 constructs, 
mixed with 3 x Ly6E GAS-LUC (9 p.g), a luciferase reporter construct 
under the control of three GAS sites from the promoter of the Ly6E 
gene, or 4x  IRF-1 GAS-LUC (9 I~g), a luciferase reporter construct 
with four GAS sites from the promoter of the IRF-1 gene, respectively, 
and a pCMV~, a ~-galactosidase expression plasrnid (2 pg; Invitrogen). 
Precipitates were left on the cells (10 crn dish) for 8 hr. Afterward, 
cells were washed with PBS and grown in DMEM supplemented with 
10% calf serum. After 12-16 hr, cells were left untreated or treated 
with IFN-7 (7 ng/rnl) for 6 hr, harvested, and assayed for luciferase 
activity according to the Promega protocol. Luciferase light units of 
extracts from untransfected cells were used as basal level, and each 
transfection was normalized to concomitant ~,-galactosidase expres- 
sion from a control-transfected vector (Ausubel et al., 1994). Each 
sample was performed in triplicate in a single experiment and repeated 
in four different experiments with similar results. 
Northern Blot Analysis 
U3A Statl~ or U3A Statlas was grown in DMEM supplemented with 
10% calf serum in the presence of G418 (100 ~g/ml) and treated with 
IFN-7 for 3 hr or left untreated. Poly(A) + RNA was selected by the 
Micro-FastTract Kit (Invitrogen), separated on 1% formaldehyde-aga- 
rose gel, and bound to k-probe membrane (Bio-Rad). Full-length cDNA 
of human IRF-1 or GAPDH was labeled with [y-32P]ATP using random 
hexamers (Sambrook et al., 1989) as probes. Hybridization was per- 
formed at 65°C in 0.25 M Na2HPO4, 7% SDS solution for 16 hr. The 
membrane was then washed at room temperature with 2 x SSC for 
10 min and at 65°C with 2x  SSC, 0.1% SDS for 20 rain, 1 x SSC, 
0.1% SDS for 20 min, 0.5x SSC, 0.1% SDS for 20 min, and 0.1 x 
SSC, 0.1% SDS for 40 min. 
COS Cell Transfection Experiments 
COS-1 cells were grown as a monolayer in DMEM with 100/O calf serum. 
Transfection was done by calciu m phosphate-DNA precipitates (Ausu- 
bel et al., 1994), with RC/CMV construct expressing either wild-type 
Stat3 or the Ser-727~Ala-727 mutant of Stat3 (20 I~g). Precipitates 
were left on the cells (10 cm dish) for 8-10 hr, washed with PBS, and 
grown in DMEM supplemented with 10% calf serum. After 30 hr of 
transfection, the cells were deprived of serum for 14 hr and treated 
with mouse EGF (100 ng/ml) for 15 rain. Extracts were prepared for 
gel mobility shift assay and immunoblot analysis. In this case, the 
nuclear extracts were used for EMSA and the immunoprecipitations 
were done with the mixture of cytoplasmic and nuclear extracts from 
the same samples. 
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